top of page

LATEST MEDIA & NEWS

Jun 20, 2024

Diverge CEO Featured in Medical Stories XLMTM: The Brave Front

X-linked myotubular myopathy (XLMTM or MTM) is a rare muscle disorder that affects just 1 in 50,000 newborn males, according to the National Organization for Rare Disorders.

Diverge CEO Featured in Medical Stories XLMTM: The Brave Front

Oct 4, 2023

Diverge TSL: Healthcare Startup Success

Diverge Translations Science Laboratory is an excellent example of a medical technology startup thriving in Milwaukee.

Diverge TSL: Healthcare Startup Success

Dec 27, 2022

BioForward Member Profile: Diverge Translational Science Laboratory, LLC

BioForward Member Profile: Diverge Translational Science Laboratory, LLC

BioForward Member Profile: Diverge Translational Science Laboratory, LLC

Nov 15, 2021

Translational and Clinical Considerations of AAV-Mediated Gene Therapy

Translational and Clinical Considerations of AAV-mediated Gene Therapy presented by Dr. Michael W. Lawlor of the Medical College of Wisconsin.

Translational and Clinical Considerations of AAV-Mediated Gene Therapy

Nov 8, 2021

Introduction to AAV-Mediated Gene Therapy

Introduction to AAV-mediated Gene Therapy presented by Dr. Michael W. Lawlor of the Medical College of Wisconsin.

Introduction to AAV-Mediated Gene Therapy

Nov 15, 2019

Mitochondrial Disease: Power Outage at a Cellular Level

Mitochondria are called the powerhouse of our human cells, but when mitochondria fail to function properly, it’s like flipping the switch of the power source off.

Mitochondrial Disease: Power Outage at a Cellular Level
bottom of page